Table 1

Baseline characteristics of all participants n(%)/(mean ​± ​SD).

Variable

Phenotype A (HA ​+ ​OD ​+ ​PCOM)

Phenotype B (HA ​+ ​OD)

Phenotype C (HA ​+ ​PCOM)

Phenotype D (OD ​+ ​PCOM)

P-value

No.participants (%)

21 (52.5)

4 (10)

10 (25)

5 (12.5)

Age (years)

24.6 ​± ​3.6

29.5 ​± ​1.7

25.6 ​± ​3.4

25.4 ​± ​4.0

0.91

Duration of infertility (years)

3.8 ​± ​2.6

6.3 ​± ​2.0

3.1 ​± ​1.4

5.4 ​± ​3.9

0.13

BMI

24.5 ​± ​3.3

29 ​± ​1.8

22.6 ​± ​3.2

24 ​± ​2.0

0.12

Waist: hip ratio

0.88 ​± ​0.1

0.9 ​± ​0.1

0.9 ​± ​0.1

0.9 ​± ​0.1

0.85

FAI

8.4 ​± ​2.0

6 ​± ​1.0

7 ​± ​2.0

3 ​± ​0.8

0.01*

AMH(ng/ml)

6.2 ​± ​1.7

3.9 ​± ​2.0

5.5 ​± ​2.5

2.4 ​± ​0.5

0.02*

FSH (mIU/ml)

5.9 ​± ​1.8

4 ​± ​1.5

7.2 ​± ​3.2

4.9 ​± ​1.7

0.08

LH (mIU/ml)

7.3 ​± ​2.5

6.2 ​± ​1.3

6.8 ​± ​3.0

8.5 ​± ​3.5

0.59

TSH (mIU/ml)

2.7 ​± ​0.6

1.9 ​± ​1.0

2.4 ​± ​0.7

2.5 ​± ​0.2

0.14

Prolactin (ng/ml)

10 ​± ​3.3

12 ​± ​4.6

9.4 ​± ​4.4

9.18 ​± ​3.2

0.65

ET (mm)

5 ​± ​2.3

6.5 ​± ​1.5

5.7 ​± ​2.0

7.4 ​± ​0.5

0.11

Women with acne (%)

12 (57)

0

6 (60)

5 (100)

0.03*

Women with hirsutism (%)

3 (14)

1 (25)

1 (10)

1 (20)

0.01*

Women with AN (%)

17 (81)

4 (100)

8 (80)

4 (80)

0.82

Women ovulated (%)

9 (43)

3 (75)

5 (50)

5 (100)

0.11

  • *P-value significant.

    AN: acanthosis nigricans, BMI: body mass index, FAI: free androgen index, AMH: anti-mullerian hormone, FSH: follicle stimulating hormone, LH: luteinizing hormone, TSH: thyroid stimulating hormone, ET: endometrial thickness.